We are excited to inform you that Cambridge Research Biochemicals is rebranding to Biosynth on June 8th, 2023. This helps to unify our expanding group companies and streamline our branding whilst providing high quality and excellent customer service. As part of the name change, we will transact under Biosynth Laboratories Ltd. We look forward to… Read more »
Addition of UK based peptide and antibody production facilities expands peptides and biologics business in UK and Europe. Staad, 09 May 2023 – Biosynth, a supplier of critical raw materials to the life science industry, announces today that it has acquired Cambridge Research Biochemicals (“CRB”), a leading independent producer of custom-made peptide and antibody tools,… Read more »
Focus on Histones Histones are a family of proteins which help organise and condense the DNA. Four core histone proteins (H2A, H2B, H3 and H4) make up the histone core around which DNA is wound to form the nucleosome. The DNA between nucelosomes is bound by the linker histone H1. Histone proteins are able to control… Read more »
Leading UK peptide and antibody producers, Cambridge Research Biochemicals (CRB) have today signed a new distribution agreement with Fluoroprobes, LLC (FPL) and Click Chemistry Tools (CCT) to add FPL and CCT’s generic fluorescent activated dyes and click chemistry enabled click-reactive dyes to their existing service portfolio. The distribution agreement grants CRB the rights to market… Read more »
23 March 2021: A Day of Reflection was a day to remember, exactly one year on from the first imposed National Lockdown in the United Kingdom and the start of the COVID-19 pandemic: a year of restrictions; social distancing; cancelled holidays and postponed celebrations; video meetings and virtual conferences; scientific innovation and achievement with now… Read more »
We continue to be open and ready to help with any Covid-19 related research work, peptides or antibodies (polyclonal and monoclonal). We have made and are selling Coronavirus (Covid-19), SARS-CoV-2; ACE2 and SARS-CoV related peptides via our online catalogue DISCOVERY Peptides. I am delighted to say we have made and validated a Coronavirus (Covid-19), SARS-CoV-2… Read more »
Like many companies and people we are celebrating a key milestone in 2020 … our 40th Anniversary in a Covid-19 lockdown. The company, Cambridge Research Biochemicals was originally incorporated on 25th July 1980. We are the second oldest Peptide company in the world and a fore-runner of Antibody generation. We will be celebrating to begin… Read more »
We are open and ready to help with any Covid-19 related research work, peptides or antibodies (polyclonal and monoclonal). We are synthesising Coronavirus (Covid-19), SARS-CoV-2; ACE2 and SARS-CoV related peptides now and will be selling them via our online catalogue DISCOVERY Peptides soon. If you need expedite delivery for peptides, we offer a 5 day… Read more »
On 14th September, 2017 The Protein and Peptide Science Group (PPSG) – special interest group within the Royal Society of Chemistry (RSC) held its annual Early Stage Researcher Meeting organised by Professor Alethea tabor (UCL) followed by the Merck-Novabiochem’s 12th ‘Chemistry and Biology of Peptides Meeting’ for seasoned Peptide Researchers organised by Dr Peter White (Merck-Novabiochem).
Highly Specific Affinity Purified Polyclonal Antibodies Circadian rhythms affect many metabolic pathways, for example the phylogenetically conserved peroxiredoxin (PRX) proteins, show daily rhythms in oxidation state. To explore the biochemical properties of the PRX system, Dr John O’Neill, based at the Laboratory of Molecular Biology in Cambridge enlisted the assistance of Cambridge Research Biochemicals to prepare… Read more »